Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +972-77-2005042
  • Blog
  • Journalists
  • GDPR
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +972-77-2005042 from 8 AM - 11 PM IL

    • Contact
    • Contact

      +972-77-2005042
      from 8 AM - 11 PM IL

  • When typing in this field, a list of search results will appear and be automatically updated as you type.

  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR

DiA Imaging Analysis Partnered With Edan Instruments to Accelerate the Adoption of DiA's AI-based Cardiac Ultrasound Solutions

DiA's AI-based cardiac analysis solutions will be offered as an integrated part of Edan's ultrasound devices


News provided by

DiA Imaging Analysis

27 Aug, 2019, 19:07 IDT

Share this article

Share toX

Share this article

Share toX

BE'ER SHEVA, Israel, and SHENZEN, China, Aug. 27, 2019 /PRNewswire/ -- DiA Imaging Analysis Ltd. (DiA), a leading provider of artificial intelligence (AI)-powered ultrasound analysis solutions, announced a partnership with Edan Instruments Inc., a leading medical products and services company.

Ultrasound is a $7B market rapidly growing, adding new users in various point-of-care settings. Yet, acquiring the right image and analyzing it is still difficult and done mostly visually, which highly depends on the user's experience.

DiA's AI-based cardiac solution, LVivo Toolbox, provides a fast and objective cardiac ultrasound analysis that assists in reducing the subjectivity and increasing the efficiency of clinician's decision-making process. LVivo Toolbox could be easily used by clinicians with various levels of experience and fits to operate as an integrated add-on solution on ultrasound devices and Healthcare IT systems.

"Edan provides innovative and high-quality medical products and services, bringing the most ground-breaking imaging technologies to its customers that best fit their clinical setting and needs". Said Renfu Zhang, Edan's ultrasound product line director. "With DiA's AI-based cardiac solution, we will offer our customers an additional layer of automated AI-based analysis, as part of their everyday workflow".

Edan Instruments, a leading medical equipment supplier, has developed unique ultrasound devices that offer advanced imaging technologies, dual touch screens and a gesture-control user interface, supporting a wide range of clinical applications and delivering excellent image clarity.

"We are thrilled to partner with Edan Instruments and join forces to offer Edan's customers objective and fast clinical indications that they often struggle to find visually", said Hila Goldman Aslan, DiA's CEO and co-founder.  

DiA's CEO's will talk about the Future of AI in cardiac ultrasound at the European Society of Cardiology (ESC) conference's Data Analysis session - September 2nd, 12:30PM, Digital Health Area - Stage 2; Edan will be exhibiting at booth #W100.

About DiA Imaging Analysis

DiA Imaging Analysis Ltd. is the leading provider of artificial intelligence (AI)-powered ultrasound analysis solutions that make ultrasound analysis smarter and accessible. By using its advanced AI-based technology, DiA assists clinicians at all levels of experience to acquire and analyze ultrasound images - objectively and accurately, improving patient management.

DiA's solutions are cross-platform that can be easily implemented to ultrasound devices and healthcare IT systems, as an integrated part of clinician's workflow.

Headquartered in Israel with a subsidiary in the US, the company was founded by Hila Goldman Aslan (CEO), Michal Yaacobi (CTO), Arnon Toussia-Cohen (CCO) and Dr. Noah Liel-Cohen. For more information please visit www.dia-analysis.com

About Edan Instruments

Edan Instruments Inc. is a healthcare company principally engaged in the research, development, manufacture, sales of medical electronic equipment products and in-vitro diagnostic products, as well as the provision of related services.

Edan owns over 300 patents and software copyrights worldwide which contribute to ongoing growth through a distributor-based globalization strategy. Edan is proud to offer high-quality medical equipment for many product categories including Obstetrics & Gynecology Patient Monitoring; Diagnostic Electrocardiographs; Ultrasonic Imaging Systems and others.

As an R&D driven company, Edan deploys cutting edge technologies and develops products to satisfy the needs of many markets around the world. For more information please visit www.edan.com.cn/html/en/

Contact DiA:
Edith Schlanger
Marketing Manager
+972-77-7648318
[email protected]

Contact Edan: 
Alice Bai
Marketing Manager
+86-755-26897625
[email protected]

SOURCE DiA Imaging Analysis

Related Links

http://www.dia-analysis.com

Modal title

Contact PR Newswire

  • +972-77-2005042
    from 8 AM - 11 PM IL

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Csezh
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italie
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+972-77-2005042
from 8 AM - 11 PM IL
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2026 Cision US Inc.